Rhino-orbital mucormycosis in a diabetes patient with renal impairment after amphotericin B deoxycholate: the role of amphotericin B lipid-complex treatment
Journal: Journal of Health and Biological Sciences (Vol.9, No. 1)Publication Date: 2021-04-08
Authors : Italo Gustavo Lima Monteiro; Luis Arthur Brasil Gadelha Farias; Ruth Maria Oliveira de Araújo; Licia Borges Pontes;
Page : 1-4
Keywords : Mucormycosis; Amphotericin B; Liposomal Formulation; Drug Therapy;
Abstract
Introduction: Mucormycosis is an infection caused by the ubiquitous saprophyte fungi with rapid and aggressive progression, especially in immunocompromised patients. Case report: A 57-year-old woman diagnosed with rhino-orbital mucormycosis presented with decreased renal function after treatment with amphotericin B deoxycholate which was discontinued. Renal function improved after amphotericin B lipid-complex, being also treated with itraconazole, and otorhinolaryngological surgery. Conclusion: The use of Amphotericin B deoxycholate may result in adverse effects. In this situation, Amphotericin B lipid formulation is usually the drug of choice.
Other Latest Articles
- Condições de saúde bucal em pessoas acometidas por Covid-19
- As repercussões da gravidez no cotidiano de uma mulher
- Avaliação do perfil metabólico dos pacientes transplantados do coração no Hospital de Messejana
- The Prevalence and Severity Comparison of COVID-19 Disease in SAARC Affiliated Countries: Pattern Analysis during the First Wave in 2020
- Analysis of respiratory complications occasioned by the coronavirus (COVID-19): a systematic review
Last modified: 2021-06-16 01:51:09